In a groundbreaking study, researchers have developed a novel nasal spray that targets the root cause of chronic neuroinflammation in Alzheimer’s disease, leading to promising improvements in brain health. The treatment significantly reduced inflammation in the brain and helped prevent the build-up of plaques and proteins linked to the progressive loss of neurons, a hallmark of Alzheimer’s.
The innovative approach, developed by Ashok K. Shetty, Ph.D., a University Distinguished Professor and associate director at the Institute for Regenerative Medicine, and his collaborator Madhu LN, Ph.D., uses extracellular vesicles derived from neural stem cells. These vesicles, delivered through a nasal spray, are capable of non-invasively targeting cells involved in sustaining neuroinflammation in the brain.
Continue reading… “Nasal Spray Targeting Chronic Neuroinflammation Shows Promise in Alzheimer’s Treatment”